Hypera Pharma
-
Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Read More » - Technology
Hypera Pharma Switches to Rimini Street Support for Its SAP Applications
Hypera Pharma Switches to Rimini Street Support for its SAP Applications (Photo: Business Wire) Sao Paulo, Brazil & Las Vegas,…
Read More »